Post-transplant Burkitt's leukemia or lymphoma.: Study of five cases treated with specific intensive therapy (PETHEMA ALL-3/97 trial)

被引：14

作者：

Xicoy, B

Ribera, JM

Esteve, J

Brunet, S

Sanz, MA

Fernández-Abellán, P

Feliu, E

机构：

[1] Hosp Univ Germans Trias & Pujol, Hematol Hemotherapy Dept, Hematol Serv, Barcelona 08916, Spain

[2] Hosp Clin Barcelona, Barcelona, Spain

[3] Hosp Santa Creu & Sant Pau, Barcelona, Spain

[4] Hosp La Fe, E-46009 Valencia, Spain

[5] Hosp Univ, Alicante, Spain

来源：

LEUKEMIA & LYMPHOMA | 2003年 / 44卷 / 09期

关键词：

posttransplant; Burkitt's lymphoma; leukemia; therapy;

D O I：

10.3109/10428190309178777

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Burkitt's lymphoma (BL) and Burkitt-like acute lymphoblastic leukemia (ALL) are uncommon lymphoproliferative disorders after solid organ or stem cell transplantation. Although their prognosis is considered to be poor, there are scarce data on the clinical characteristics and the response to specific therapies. We report the main clinical characteristics and the results of a specific intensive chemotherapy in 5 adult patients with postransplant BL/ALL3 included in the, PETHEMA ALL3/97 protocol. Two patients died in induction, another died in consolidation phase and the remaining 2 patients are in continuous complete remission 6 and 18 months from the diagnosis.

引用

页码：1541 / 1543

页数：3

共 6 条

[1] PROPOSALS FOR CLASSIFICATION OF ACUTE LEUKEMIAS [J].

BENNETT, JM ;

CATOVSKY, D ;

DANIEL, MT ;

FLANDRIN, G ;

GALTON, DAG ;

GRALNICK, HR ;

SULTAN, C .

BRITISH JOURNAL OF HAEMATOLOGY, 1976, 33 (04) :451-&

[2] Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas [J].

Cheson, BD ;

Horning, SJ ;

Coiffier, B ;

Shipp, MA ;

Fisher, RI ;

Connors, JM ;

Lister, TA ;

Vose, J ;

Grillo-López, A ;

Hagenbeek, A ;

Cabanillas, F ;

Klippensten, D ;

Hiddemann, W ;

Castellino, R ;

Harris, NL ;

Armitage, JO ;

Carter, W ;

Hoppe, R ;

Canellos, GP .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (04) :1244-1253

[3] World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting - Airlie House, Virginia, November 1997 [J].

Harris, NL ;

Jaffe, ES ;

Diebold, J ;

Flandrin, G ;

Muller-Hermelink, HK ;

Vardiman, J ;

Lister, TA ;

Bloomfield, CD .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (12) :3835-3849

[4]

Harris NL, 1997, SEMIN DIAGN PATHOL, V14, P8

[5] Epstein-Barr virus associated Burkitt lymphoma in a heart transplant recipient [J].

Hunt, BJ ;

Thomas, JA ;

Burke, M ;

Walker, H ;

Yacoub, M ;

Crawford, DH .

TRANSPLANTATION, 1996, 62 (06) :869-872

[6] Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: A retrospective analysis on 32 patients [J].

Milpied, N ;

Vasseur, B ;

Parquet, N ;

Garnier, JL ;

Antoine, C ;

Quartier, P ;

Carret, AS ;

Bouscary, D ;

Faye, A ;

Bourbigot, B ;

Reguerre, Y ;

Stoppa, AM ;

Bourquard, P ;

de Ligny, BH ;

Dubief, F ;

Mathieu-Boue, A ;

Leblond, V .

ANNALS OF ONCOLOGY, 2000, 11 :113-116

← 1 →